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Abstract
In the kidney, the renal proximal tubule (PT) reabsorbs solutes into the peritubular capillaries
through active transport. Here, we replicate this reabsorptive function in vitro by engineering
a microfluidic PT. The microfluidic PT architecture comprises a porous membrane with
user-defined submicron surface topography separating two microchannels representing a
PT filtrate lumen and a peritubular capillary lumen. Human PT epithelial cells and microvas-
cular endothelial cells in respective microchannels created a PT-like reabsorptive barrier.
Co-culturing epithelial and endothelial cells in the microfluidic architecture enhanced viabil-
ity, metabolic activity, and compactness of the epithelial layer. The resulting tissue
expressed tight junctions, kidney-specific morphology, and polarized expression of kidney
markers. The microfluidic PT actively performed sodium-coupled glucose transport, which
could be modulated by administration of a sodium-transport inhibiting drug. The microfluidic
PT reproduces human physiology at the cellular and tissue levels, and measurable tissue
function which can quantify kidney pharmaceutical efficacy and toxicity.
Introduction
The human kidney regulates solute and water homeostasis, excretes metabolic waste, produces
hormones, and maintains acid-base balance [1]. The nephron, the basic structural and func-
tional unit of the kidney, has two key segments: the glomerulus, which filters the blood, and
the tubule, which reabsorbs components of the filtrate into the peritubular capillary network.
The proximal tubule (PT) segment reabsorbs the bulk of the filtered load into the bloodstream
driven mainly by active sodium transport, while distal and collecting duct segments fine-tune
the composition of the remaining filtrate to maintain volume and tonicity. Diabetes mellitus,
high blood pressure, autoimmunity, off-target effects of certain drugs, or other insults generate
defects in the glomerulus or PT, impairing the crucial kidney functions of filtration and/or
reabsorption. These defects present clinically as loss of proteins, impaired metabolic and ionic
homeostasis, and decreased clearance, potentially leading to advanced kidney failure.
In the PT, human renal proximal tubule epithelial cells (hRPTEC) form a polarized epithe-
lial barrier enabled by cell-cell tight junctions (TJs). The main function of the barrier is
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selective reabsorption, largely dictated by the sodium-potassium adenosine triphosphatase
(Na+/K+-ATPase) of the hRPTEC. An underlying basement membrane supports hRPTEC tis-
sue, supplies chemical and mechanical signals, and separates the tissue from interstitial space
and surrounding microvasculature. Generally, cells integrate various external signals including
extracellular matrix (ECM) components, mechanical stimulation, and soluble signals from
adjacent and distant cells. Tissue structure formation depends on critical information from the
extracellular microenvironment to cue tissue orientation, energy metabolism and differentia-
tion. The complex reabsorptive function of the kidney directly results from the specific tissue
structure formation of the proximal tubule and surrounding peritubular microvasculature
[2,3,4]. Therefore, an in vitro model that replicates the PT microenvironment will enable phys-
iological tissue structure formation and direct quantification of renal reabsorptive function.
Advanced in vitro PT kidney models have incorporated physiological signals into the cul-
ture environment, such as fluid flow, ECM proteins and multiple cell types[5,6,7]. However,
physiological reabsorption in the proximal tubule takes place across opposing monolayers of
epithelium and endothelium separated by a basement membrane (BM), which is not replicated
in these advanced models. Co-incubation of endothelial and epithelial cells in culture dishes
show altered ECM expression and transport proteins in hRPTEC [8,9], which highlights the
importance of the endothelial-epithelial co-culture. A PT model comprising epithelial and
endothelial co-culture opposing each other in a physiological orientation with access to con-
trolled levels of flow-induced shear stress (FSS), BM topography and tissue-probing metrics,
represents a significant improvement in kidney models and may allow direct measurement of
reabsorptive transport function in vitro.
We present an in vitro three-dimensional microfluidic model of the (PT) reabsorption bar-
rier designed to allow precise control over the microenvironment, physiological tissue struc-
ture formation, and direct evaluation of renal-specific reabsorptive function. We developed a
co-culture of an hRPTEC layer opposing a human microvascular endothelial cell (hMVEC)
layer in a microfluidic PT, mimicking the architectural design of the renal proximal tubule
(Fig 1A and 1B). The presence of hMVEC in the microfluidic PT increased hRPTEC prolifera-
tion such that the hRPTEC count was more than double after 7 days of culture compared to
single cultures of hRPTEC. Tissue layers were more compact with higher mitochondrial activ-
ity per cell and hRPTEC viability was supported for at least two weeks in co-culture. The
microfluidic PT expressed kidney-specific transport proteins, the sodium-glucose linked trans-
porter-2 (SGLT2), the Na+/K+-ATPase, and aquaporin 1 (AQP1), required for transepithelial
water and ion transport. The microfluidic PT demonstrated inhibition and recovery of active
reabsorption of a fluorescent glucose analog, 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-
2-deoxyglucose (2-NBDG), in response to modulation of the drug ouabain. The model repli-
cates both the structure and active function of the in vivo PT reabsorptive barrier, thus provid-
ing a platform with a functional metric to study the response of tissue to external stimuli,
tissue structure development, transport mechanisms, and PT injury.
Materials and methods
Microfluidic PT device assembly
Polycarbonate track-etched membranes were hot embossed with sub-micron surface topogra-
phy and assembled into a multilayer microfluidic device, described previously [10]. Briefly, the
membrane was bonded to each channel layer with an RTV silicone adhesive (Dow Corning,
Midland, MI) such that the patterned side of the membrane served as the floor to one of the
cell chambers. The bottom microfluidic channel layer was then oxygen plasma bonded to a
A microfluidic proximal tubule
PLOS ONE | https://doi.org/10.1371/journal.pone.0184330 October 11, 2017 2 / 15
Charles Stark Draper Laboratory, Award: Draper
Research and Development Grant, Recipient/PI:
Joseph Leo Charest, Ph.D.; and Charles Stark
Draper Laboratory, Award: University Research
and Development Grant, Recipient/PI: M. Amin
Arnaout, M.D. The funders had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
glass coverslip. Devices with incomplete bonding or irregular channel geometry were dis-
carded prior to cell culture.
Cell culture and seeding cells in the device
Normal-human microvascular endothelial cells (Lonza, CC-2543) expressed alpha actin and
were tested negative for mycoplasma in compliance with Lonza’s Quality System. hMVEC
were passaged twice prior to seeding them in the device and were maintained in hMVEC-com-
plete media (growth media and supplements, Lonza, CC-3202) containing supplements of
human epithelial growth factor (hEGF), hydrocortisone, 5% FBS, VEGF, hFGF-B, R3-IGF-1,
ascorbic acid and GA-1000 (gentamycin, Amphotericin-B). Human renal proximal epithelial
cells (hRPTEC) (ScienCell, #4100) were characterized according to ScienCell Quality Control
and demonstrated expression of cytokeratin-18, -19 and vimentin and were negative for myco-
plasma DNA measured by PCR. hRPTEC were passaged once prior to seeding them in the
device and were maintained in hRPTEC complete media, a DMEM-F12 base supplemented
with 0.5% FBS, 10ng/ml hEGF, 5 μg/ml insulin, 0.5 μg/ml hydrocortisone, 0.5 μg/ml epineph-
rine, 6.5 ng/ml Tri-idothyronine, 10 μg/ml transferrin, 100 U/ml penicillin, and 100 μg/ml
streptomycin. Media was changed every other day until passage or seeding. Cultured cells
were kept in a humidified 37˚C incubator at 5% CO2. Bilayer microfluidic devices were chosen
such that the topography on the membrane served as the cell culture surface in the epithelial
channel. Devices were plasma treated using an oxygen plasma asher to render the channels
hydrophilic and sterilized in 70% ethanol for 30 minutes. Channels were thoroughly rinsed in
PBS and then incubated with a 60 μg/ml collagen type IV (from human placenta, Sigma-
Aldrich, C-5533) solution for 2 hours at room temperature. The devices were again thoroughly
Fig 1. An in vitro 3D microfluidic model mimics the reabsorptive barrier of the proximal tubule. A) In
vivo, water and solutes cross an epithelial-endothelial barrier in the reabsorption process from filtrate tubule to
the peritubular capillaries. (B) The microfluidic channels overlap to create a filtrate channel (green) in
communication with a vascular channel (purple). The cross-sectional architecture (inset) mimics in vivo
epithelial-endothelial barrier and generates cell-mediated transport through the membrane. (C) A cross-
sectional SEM of the device shows a semi-porous membrane, which serves as a scaffold for the epithelial and
endothelial cells and separates the filtrate and vascular channels. (D) The membrane sub-micron ridge/
groove topography influences tissue organization and function.
https://doi.org/10.1371/journal.pone.0184330.g001
A microfluidic proximal tubule
PLOS ONE | https://doi.org/10.1371/journal.pone.0184330 October 11, 2017 3 / 15
rinsed in PBS before being prepped for hMVEC seeding. hMVEC were seeded into the vascu-
lar channel, and after attachment, the cells were allowed to proliferate to confluency over 3
days on the surface of the membrane. hRPTEC were then seeded into the filtrate channel and
grew to confluency over 3–4 days, with both cell types in a common media of hMVEC-com-
plete media. Confluency of the cell layers was evaluated by phase-contrast microscopy for each
device before using it for experiments. Media was exchanged in both filtrate and vascular
channels every day without applying shear stress for significant amounts of time until devices
were used for experiments at day 7–14. Tissue samples were excluded from experiments if
incomplete monolayers were observed prior to testing via phase contrast imaging. Complete
tissue layers were randomly selected for each experimental group.
Immunofluorescent labeling
Both hRPTEC and hMVEC were fluorescently labeled with antibodies directed against specific
markers for differentiated epithelia, endothelium, and transport proteins. First, cells in devices
were rinsed gently with PBS. For each rinsing, fixing, permeabilizing and labeling step, 100–
150 μl of the solution was pipetted on top of the device to form a bubble on the surface. A
micropipette was used to gently withdraw the solution through the channels several times.
Cells were fixed with a 3.7% paraformaldehyde solution for 10 minutes at room temperature.
Channels were rinsed with PBS 3 times and permeabilized with a 0.1% triton-x solution for 5
minutes at room temperature. Channels were again rinsed 3 times with PBS and blocked with
a 1% solution of FBS for 3 hours. Primary antibodies were mixed at the appropriate concentra-
tion in a 1% FBS solution. A mouse anti-ZO1 (BD biosciences, 610967) and a rabbit anti-Von
Willebrand Factor (vWF) (Abcam, ab9378) were used to label epithelial cells and endothelial
cells, respectively. Primary antibodies used to label transporter proteins included a mouse
anti- Na+/K+-ATPase pump (Santa Cruz Biotechnology, sc-48345) and a rabbit polyclonal
anti-SGLT2 transporter (Abcam, ab37296). All primary antibodies were incubated in the
device overnight at 4˚C. All channels were rinsed 3 times with PBS. Secondary antibodies were
also mixed in a 1% FBS solution with a 1:1000 dilution of Hoechst. Donkey anti-mouse IgG
(AF 488) and anti-rabbit IgG (AF 568) secondary antibodies were incubated in the channels
for 1 hour at room temperature. A final rinsing step was done with PBS 3 times before samples
were ready to image.
Cell density, viability and metabolic activity in device
The number of hRPTEC per square mm of cell culture area, both of co-culture and non-co-
culture conditions, was determined using the cell analysis software, CellProfiler. A pipeline
was written so the cell images with nuclei labeled with Hoechst were inverted, masked and the
background smoothed such that each nucleus could be identified and counted in a high
throughput, objective manner. Cell viability and metabolic activity was measured for each cell
culture condition 24 hours after seeding cells in device, using the WST-1 assay (Millipore, cata-
log no. 2210) in the same hMVEC-complete medium so as not to affect the final absorbance
reading. A 1:10 dilution of the tetrazolium salt solution was made in culture medium and incu-
bated in the device channels for 30 minutes. 100 μl of the 125 μl total volume was collected
into a 96 well plate and absorbance of the sample volume was measured at 440 nm with a refer-
ence wavelength over 600 nm using a multiwall spectrophotometer. Background absorbance
was subtracted to get final absorbance reading, which was normalized to average cell count per
square mm.
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Reabsorptive function assay
Reabsorption of the fluorescent glucose analog, 2-NBDG, served as a metric to monitor the
transport function of the PT co-culture model in our device. The reabsorption of 2-NBDG
from the filtrate/epithelial channel to the vascular/endothelial channel was observed using z-
stack microscopy coupled with time-lapse image acquisition. 2-NBDG was infused into the fil-
trate channel under control (no drug) or sodium transport-inhibited conditions (1 μM oua-
bain). The alternating use of drug and no-drug serves as an internal control to demonstrate
active reabsorption. The starting condition of either no drug or 1 μM ouabain was alternated
for each tissue sample tested. A Zeiss LSM 700 confocal microscope was used to capture all
images. A 3-slice z-stack captured intensity values of the tubule channel, the hRPTEC tissue
layer, and the vascular channel at a rate of 1 slice every 4 seconds. The scan time per frame was
3.87 seconds. The change in fluorescent intensity over time in the vascular channel corre-
sponded to the movement of 2-NBDG into that channel under control, drug, or recovery con-
ditions. All tissue samples were glucose-starved for 30 minutes prior to the experiment in
buffer containing 0.5% BSA, 5 mM sodium pyruvate and 5 mM glucose in PBS containing cal-
cium and magnesium. Under drug conditions, 1 μM of ouabain was infused via a syringe
pump into the vascular channel until the 2-NBDG signal was insignificant in the vascular
channel. The pump was stopped and the reabsorption of 2-NBDG into the vascular channel
was observed under a static environment. 2-NBDG solution was regularly replenished to keep
the 2-NBDG concentration constant in the filtrate channel. For recovery conditions, the pump
was used to rinse ouabain solution from the vascular channel. 2-NBDG solution was replen-
ished in the tubule channel and 2-NBDG reabsorption into the vascular channel was again
observed. This method was repeated with a second administration of 1 μM ouabain to further
demonstrate the dynamic reabsorptive function of the tissue model.
Imaging collection and statistics
A Zeiss Axiovert inverted epifluorescent microscope with an attached camera and the image
acquisition software, Zen Blue 2012, were used to collect cell images. Exposure time was con-
trolled during each image acquisition when comparing fluorescent intensity expressions. A
Zeiss LSM 510 confocal microscope was used to take z-stacks and single images of the co-cul-
ture samples. For each experiment, at least 5 images for each tissue layer and at least three rep-
licate samples were analyzed per group. Groups were compared for statistical significance
using a one-way ANOVA test with a paired Tukey analysis if multiple groups were being ana-
lyzed, or a t-test was used when comparing 2 groups. Variation within each group of data is
represented by error bars, defined by s.e.m. The variance was similar between all groups that
were statistically compared. The statistical analysis for the 2-NBDG transport considered the
full ensemble of data to ensure maximum statistical power and provide a complete picture of
the relationships. The data were modeled using an analysis of covariance with time as the
covariate. To capture the non-linear behavior of 2-NBDG over time, the model included time
and time squared as covariates. Main effects modeled the changes across the four phases (con-
trol, initial 1 μM of ouabain, recovery, and second 1μM of ouabain) and mean differences
across the three devices. All terms in the analysis of covariance model were highly statistically
significant (p-values < 0.0005). Thus, the analysis of covariance model indicates that 2-NBDG
intensity in the vascular channel follows a consistent pattern across all devices, with the level
rising during the control and recovery periods, but clearly depressed during the two drug
(1 μM of ouabain) conditions. Experimental results were verified for 3 independent
experiments.
A microfluidic proximal tubule
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Results and discussion
Establishing physiological human renal proximal tubule architecture and
barrier function in vitro
Sub-micron surface topography provides important signals to influence cell function in vitro
[11,12,13,14,15]. We incorporated a porous, topographically-patterned polycarbonate mem-
brane into the microfluidic PT, with 750 nm wide grooves that are within an order of magni-
tude of the sub-micron feature sizes observed in renal BM [16,17]. The embossed membranes
separated a microchannel representing the tubule filtrate lumen from a microchannel repre-
senting the microvascular lumen, with the patterned side of the membrane serving as the floor
of the epithelial cell chamber as shown in Fig 1C and 1D. The device retained the ability to
apply FSS, with levels similar to those found in renal tubules in vivo of 0.3–1 dynes/cm2
[18,19], although it was employed with the topographical patterns without application of FSS
for a significant duration. We have previously shown that the micropatterned topography
enhanced formation of tight epithelial cell monolayers compared to cell populations cultured
on non-topographical surfaces, in both the presence and absence of FSS [20]. Further charac-
terization of the influence of the topography in the current configuration could be evaluated in
future studies.
One channel of the microfluidic device overlaps with the other to create a renal epithelial
filtrate channel in communication with an endothelial vascular channel, shown in Figs 1B and
2A. hRPTEC and hMVEC formed confluent tissue layers on either side of the topographically
patterned membrane, shown in Fig 2B. The TJ protein, ZO-1, was expressed in the hRPTEC
layer as shown in Fig 2C, while the hMVEC layer expressed the endothelial-specific marker
Fig 2. hRPTEC and hMVEC in close-contact co-culture form a physiological PT tissue barrier. (A) The
microfluidic channels overlap to create a renal epithelial filtrate channel in communication with an endothelial
vascular channel. (B) A close-contact co-culture of hRPTEC and hMVEC were grown in channels on opposite
sides of the membrane. hRPTEC were labeled with anti-ZO-1 (green) and hMVEC with anti-vWF (red). (C, D)
Confocal slices of the co-cultured cells show a confluent hRPTEC tissue layer and hMVEC tissue layer with
clear ZO-1 (green) and vWF (red) expression, respectively. Each tissue layer exists in the xy plane, but is
separated in the z-axis by the membrane. Scale bars: 30 μm. (E) A collapsed xz view of the co-culture stack
shows clear separation between the tissue layers and a thicker epithelial tissue layer vs. endothelial layer. (F)
A z-profile plot illustrates the change in average intensity expression, normalized to respective blank channel
intensity values, of ZO-1 and vWF signals through the 14 μm co-culture 3D tissue stack. The width of the
peaks correspond to each cell layer thickness, indicating a cuboidal morphology of the hRPTEC tissue in and
a squamous morphology of hMVEC tissue. At least 3 replicate samples were repeated over at least 3 batches
of experiments.
https://doi.org/10.1371/journal.pone.0184330.g002
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von Willebrand Factor (vWF) as shown in Fig 2D. Each tissue layer covered the width of the
channel without exhibiting edge effects at the channel walls. Fig 2E shows a collapsed xz plane
view, illustrating the hRPTEC layer (green) with a more cuboidal morphology, mimicking the
in vivo state [21], compared to the thinner hMVEC layer (red), reflecting the expected squa-
mous-like morphology. The non-colored interspace indicated the location of the porous mem-
brane. The average intensity of each tissue slice for a given fluorescent channel was quantified
in a z-profile intensity plot profile shown in Fig 2F. The tissue stack spanned 14 μm, starting
with the hRPTEC tissue layer at 0–8 μm and ending with the hMVEC tissue layer at 11–14 μm.
The membrane, indicated by the drop in intensity at 8–11 μm, clearly separated the two tis-
sues. The width of the 2 peaks was indicative of cuboidal and squamous morphologies of the
respective epithelial and endothelial cells, which corresponds with the cross section seen in Fig
2E. Thus, the co-culture architecture mimicked the physiological structure of a renal proximal
tubule, placing the basolateral sides of hRPTEC and hMVEC layers in close proximity, sepa-
rated by the ECM-coated porous membrane. The tissue structure and protein expression illus-
trated by the confocal microscope z-stacks indicated formation of tissue layers with polarized
renal morphology. This morphology allowed study of renal-specific transport function across
both tissue layers, similar to the complete pathway solute and water take to transfer from the
tubule lumen to the microvascular space in vivo.
hRPTEC monolayer formation and activity are enhanced in the presence
of hMVEC
hRPTEC monolayer formation in the microfluidic PT model was highly influenced by the
presence of the hMVEC. hRPTEC cells grown in device channels without the presence of
hMVEC cells stop proliferating and lose their phenotype after 3 days of culture. Fig 3A and 3B
illustrates the tissue layer structural differences between hRPTEC monoculture and hRPTEC/
hMVEC co-culture conditions. Over a 7-day culture period, hRPTEC tissue layers were more
compact with a higher cell count per surface area and better-developed TJs (green) under co-
culture conditions compared to hRPTEC-only conditions. hRPTEC tissue layers formed in
mono-culture conditions had 43% less cells per surface area when cultured over the same time
period as co-culture conditions, as shown in Fig 3C. hRPTEC tissue layers cultured in mono-
culture conditions using the hMVEC media did not survive to form monolayers and were
therefore not included in the analysis. Mitochondrial activity of the hRPTEC, measured using
the WST-1 bioassay, was enhanced by the presence of hMVEC as shown in Fig 3D. The absor-
bance signal indicating mitochondrial activity was normalized to the average cell number/
mm2. The contribution of mitochondrial activity from the hMVEC tissue was negligible, data
not shown. The addition of hMVEC tissue into the model also sustained hRPTEC tissue viabil-
ity for at least 15 days without requiring additional channel perfusion or FSS application.
Heterotypic cell-cell communication present in co-culture environments influences cellular
functions including proliferation [22,23], differentiation [24,25], and tissue structure forma-
tion [26,27,28,29,30]. In the proximal tubule, because reabsorption of water and solutes occurs
through epithelial and endothelial monolayers, both cells types were incorporated into our
device to mimic the orientation, separation, and composition of the co-culture found in vivo.
We speculate that the hMVEC tissue layers were secreting multiple soluble factors, which can
have an effect on proximal tubule tissue development[31]. It was expected that cell types, such
as hRPTEC and hMVEC, which exist in close proximity in the body, will influence each other
in vitro, which was consistent with our data of a more compact hRPTEC tissue layer, enhanced
hRPTEC proliferation and increased hRPTEC mitochondrial activity when in co-culture with
hMVEC. The higher mitochondrial activity per cell, whether due to increase in mitochondria
A microfluidic proximal tubule
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Fig 3. hMVEC presence enhances the hRPTEC layer. (A, B) TJ formation in 7-day cultures of hRPTEC
without and with hMVEC in the microfluidic device, respectively. hRPTEC formed a more compact tissue layer
with clear TJ formation under hRPTEC/hMVEC co-culture conditions. hRPTEC were labeled with anti-ZO-1
(green) and Hoechst (blue). At least 5 images for each tissue layer and at least three replicate samples were
analyzed per group. (C) Average number of hRPTEC/mm2 in co-culture conditions is more than double that of
hRPTEC-only conditions after 7 days of culture. * P < 0.001. Results were verified for 3 independent
experiments. (D) hRPTEC in co-culture conditions have increased mitochondrial activity compared to
hRPTEC-only conditions, normalized to cell count. The mitochondrial activity of hMVEC cells in co-culture is
negligible. * P = 0.002. Error bars represent standard error of the mean from 3 independent tissue samples.
https://doi.org/10.1371/journal.pone.0184330.g003
A microfluidic proximal tubule
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number or individual mitochondria efficiency, may also influence or indicate presence of
energy-dependent functions such as active transport[32].
Very few models have been developed to incorporate microvascular tissue to mimic reab-
sorptive barriers in vitro [33,34]. Transwells provide either a non-contact orientation with a 1
mm distance between the two cell types, or cells on both sides of the Transwell insert mem-
brane to establish an approximation of a close-contact orientation of the two cell types[35,36].
The second orientation provides a more realistic architecture, but the Transwells deprive cells
of physiological cues [19,37], such as BM topography and FSS which are present in vivo and
accommodated in our model.
To demonstrate and directly quantify this active reabsorption function in the microfluidic
PT, we used the fluorescent glucose analog 2-NBDG[38] to monitor reabsorption in the
absence and presence of the Na+/K+-ATPase inhibitor ouabain [39,40,41]. 2-NBDG is trans-
ported by SGLT2 and GLUT2 in cultured kidney cells [42,43,44], and its transport has been
directly quantified by fluorescent microscopy [38,45]. The hRPTEC in the device expressed
both the Na+/K+-ATPase localized to the basolateral domain and SGLT2 localized to the apical
domain, shown in the IF stained images and inset confocal cross sections in Fig 4A. The device
enables the direct quantification of morphology and transport in real time, since its architec-
ture allows a high magnification/low working distance objective and a low volume of fluid to
minimize dilution of the transported species. These two features enable precise evaluation of
concentration, which would not be possible in either a larger volume Transwell system or
would be difficult in 3D microfluidic systems with a non-planar, round channel geometries
[45]. In contrast to a proximal tubule model with a round cross sectional area[45], the two-
channel microfluidic architecture used here enables physiological delivery of glucose or glu-
cose analog via the filtrate channel and transport-inhibiting drugs via the vascular channel as
would be the case in vivo. In addition, microfluidic delivery of 2-NBDG, ouabain and a placebo
can be controlled independently, which allows for sequential administration of experimental
conditions, rather than being limited to a comparison to separate experimental controls. Fur-
thermore, the device architecture ensures quick evaluation of monolayer quality before, during
and after experimentation since the tissue layer can be directly imaged in the same focal plane
with a 40x objective. Transport of 2-NBDG from the filtrate channel to vascular channel, rep-
resented in an experimental schematic shown in Fig 4B, was examined over 4 sequential condi-
tions: 1) control without ouabain; 2) 1 μM ouabain; 3) recovery of reabsorption after rinsing
ouabain out from the vascular channel, and 4) repeat dosing of 1 μM ouabain. The alternation
of ouabain and control without ouabain served as an internal control. The transport of
2-NBDG from the filtrate channel to the vascular channel of the microfluidic PT was quanti-
fied by plotting 2-NBDG concentrations in the vascular channel as it was sequentially exposed
to the 4 conditions. An example plot from one microfluidic PT is shown in Fig 4C. The
2-NBDG concentration in the vascular channel increased approximately 8-fold over 20 min-
utes under control conditions as 2-NBDG was transported from the filtrate to vascular chan-
nel. Perfusion of 1 μM ouabain through the vascular channel decreased the 2-NBDG
concentrations as 2-NBDG was flushed from the channel for 10 minutes. After perfusion of
ouabain, little to no transport of 2-NBDG was observed in the vascular channel. Once ouabain
was rinsed from the system, 2-NBDG concentrations in the vascular channel sharply increased
over 15 minutes, indicating recovery of tissue transport function. A repeat rinsing with and
dosing of 1 μM ouabain resulted in a marked reduction of 2-NBDG transport compared to the
2-NBDG transport in recovery or control conditions. As a measure of transport rate, Fig 4D
plots the mean 2-NBDG concentration in the vascular channel over 15 minutes of each experi-
mental condition for three independent replications of the experiment. The grouped data cor-
roborated the dynamic reabsorptive function exhibited in the time plot. Transport of 2-NBDG
A microfluidic proximal tubule
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Fig 4. The microfluidic PT model altered sodium-dependent reabsorption of glucose analog in
response to ouabain. (A) hRPTEC expressed polarized transport proteins Na+/K+ ATPase and SGLT2
under co-culture conditions. (B) A schematic representation of experimental conditions. Under all conditions,
the transport of a fluorescent glucose analog, 2-NBDG, from the filtrate channel (top) into the vascular
channel (bottom) was observed using confocal z-stack and time-lapse microscopy to quantify intensity in the
vascular channel. (C) 2-NBDG intensity versus time for one device subjected to all conditions sequentially
A microfluidic proximal tubule
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recovered to control levels or higher when ouabain was rinsed from the microfluidic PT. A
repeat dose of ouabain induced a second decrease in reabsorption to less than half of the aver-
age of the recovery concentration. This measure of transport indicates significantly different
reabsorption of the glucose analog due to presence of ouabain. The dynamically-responsive
transport of 2-NBDG in response to ouabain indicated active reabsorptive function across
intact, polarized epithelial and endothelial cell monolayers in the microfluidic PT device.
In vitro models of kidney tissue are commonly characterized by the expression of transport
proteins [46], secretion of factors [47], and the uptake, rather than reabsorption, of solutes
such as glucose and sodium [44]. These approaches imply functional properties of in vivo kid-
ney tissue, but do not directly demonstrate those functions, the most important of which is
reabsorption. Our model configures the tissue layer to allow the reabsorption to occur across a
complete epithelial-to-endothelial barrier, while directly quantifying the active reabsorption
function [48]. The optical access in our model ensures the evaluation of morphology and
expression, while adding a direct measurement of active kidney function and maintaining the
ability to evaluate secretion or uptake.
Engineered structural features enabled the microfluidic PT to demonstrate the major func-
tion of the proximal tubule: reabsorption of water and solute. This active solute reabsorption
depends on parameters such as formation of tight epithelial and endothelial monolayers, and
polarized expression of transporters[48]. We demonstrated this function, and consequently its
dependent parameters, by direct measurement of sodium-coupled glucose transport from the
filtrate channel to the microvascular channel. Immunofluorescent labels demonstrated expres-
sion of the epithelial Na+/K+-ATPase pump and glucose transporter SGLT2 in our co-culture
system. Application of the fluorescent glucose analog, 2-NBDG, in the filtrate channel led to
an increase in fluorescence intensity in the vascular compartment. This transcellular move-
ment of glucose required active sodium transport, since inhibiting the sodium pump with oua-
bain delivered through the vascular channel led to ~85% reduction in glucose reabsorption
within 15 minutes. The effect was reversed when the drug was rinsed away from the epithelial
channel, and was repeated when the drug was introduced a second time. Ouabain binds with
high affinity to the Na+/K+-ATPase pump in normal kidney cells and it was expected that
1 μM would inhibit at least 70% of the pump’s activity [40], which is similar to the 85% reduc-
tion of glucose reabsorption seen in our devices. The recovery of reabsorptive function and
repeat decrease of 2-NBDG transport in response to ouabain in our kidney model confirms
the alterations in transport of 2-NBDG are due to the drug acting on transport proteins of the
transcellular pathway and not to changes in TJ permeability or in other paracellular pathways.
It is unknown if the endothelial layer influences the reabsorptive function of the epithelial
layer, although we saw that in non-co-culture conditions, the epithelial monolayer was incon-
sistent and difficult to maintain more than 2–3 days in the device. Moreover, both layers are
needed to recapitulate the in vivo transport pathway, which necessitated their simultaneous
use here. This is a clear demonstration of sodium-coupled glucose transport in a proximal
tubule-like device, in contrast to previous models, which do not demonstrate transport directly
shows the reduction in active transport due to ouabain administration. (D) The bar graph indicates the mean
2-NBDG intensity in the vascular channel at each condition, measured over ~15 minutes for 3 devices. Data
are from 3 replicates of the experiment. Error bars represent standard error of the main effects as computed
from the error term in the analysis of covariance model. Introducing ouabain to the vascular channel blocked
2-NBDG transport. The 2-NBDG transport recovered when ouabain was rinsed from the system. A second
administration of ouabain again blocked 2-NBDG transport. The tissue recovery and repeat effect of ouabain
demonstrates dynamic reabsorptive cell-mediated reabsorption function. * P < 0.0005. Experimental results
were verified for 3 independent experiments.
https://doi.org/10.1371/journal.pone.0184330.g004
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[42,49,50]. The presence of this complex reabsorptive function in our microfluidic model is
significant because it demonstrates the ability of an in vitro system to recapitulate a major
function of the proximal tubule, in addition to replicating physiological architecture and
molecular uptake.
Conclusion
In conclusion, we have engineered a proximal tubule-like tissue in a microfluidic device,
which copies major structural, morphologic, and cellular components of the in vivo proximal
tubule. Our microfluidic PT platform has two key structural features engineered to mimic nor-
mal PT tissue architecture, which distinguish it from previous models. First, the incorporation
of endothelial-epithelial co-culture while leveraging microfluidic architecture, and second, the
device architecture allows direct monitoring and measurement of cellular morphology and
functional responses in real time. Importantly, the engineered microfluidic PT replicates the
kidney-specific active function of reabsorption essential to this nephron segment. Such a
device could be linked to proximal and distal nephron components, each populated by special-
ized cells providing a basis for a kidney rebuilding strategy. The current device is set up for
future investigation of the effects of sub-micron surface topography on epithelial and endothe-
lial function in this coculture system, assessment of additional transporter function, including
organic anion and cation transport, and evaluation of the influence of FSS in one or both tissue
compartments. The microfluidic PT can reconstruct human kidney physiology and function
at the cellular and tissue level, screen new drugs for potential kidney toxicity without the need
for animal models, elucidate the mechanism of action of kidney-acting drugs, and be scaled to
generate a clinically-relevant construct or device with proven kidney function.
Acknowledgments
We thank Dr. Hyoungshin Park and Dr. Rachelle Prantil-Baun for technical assistance and Dr.
John Irvine for statistical analysis.
Author Contributions
Conceptualization: Else M. Vedula, Jose´ Luis Alonso, M. Amin Arnaout, Joseph L. Charest.
Data curation: Else M. Vedula, Joseph L. Charest.
Formal analysis: Else M. Vedula, Joseph L. Charest.
Funding acquisition: M. Amin Arnaout, Joseph L. Charest.
Investigation: Else M. Vedula, M. Amin Arnaout, Joseph L. Charest.
Methodology: Else M. Vedula, Jose´ Luis Alonso, Joseph L. Charest.
Project administration: M. Amin Arnaout, Joseph L. Charest.
Resources: M. Amin Arnaout, Joseph L. Charest.
Supervision: M. Amin Arnaout, Joseph L. Charest.
Visualization: Joseph L. Charest.
Writing – original draft: Else M. Vedula, M. Amin Arnaout, Joseph L. Charest.
Writing – review & editing: Else M. Vedula, Jose´ Luis Alonso, M. Amin Arnaout, Joseph L.
Charest.
A microfluidic proximal tubule
PLOS ONE | https://doi.org/10.1371/journal.pone.0184330 October 11, 2017 12 / 15
References
1. Al-Awqati Q (2012) Structure and Function of the kidneys. Goldman’s Cecil Medicine. Publisher, Else-
vier Saunders, Philadelphia, PA, 19103. 24th Edition, 716–720.
2. Christensen EI, Wagner CA, Kaissling B (2012) Uriniferous Tubule: Structural and Functional Organiza-
tion. Comprehensive Physiology 2: 805–861. https://doi.org/10.1002/cphy.c100073 PMID: 23961562
3. Kaissling B, Le Hir M (2008) The renal cortical interstitium: morphological and functional aspects. Histo-
chem Cell Biol 130: 247–262. https://doi.org/10.1007/s00418-008-0452-5 PMID: 18575881
4. Kriz W, Kaissling B (2008) Structural and Functional Organization of the Kidney. In: Sa Geibisch, editor.
The Kidney: Elsevier Inc. pp. 479–563.
5. Frohlich EM, Charest JL (2013) Chapter 11—Microfabricated Kidney Tissue Models. In: Bettinger C,
Borenstein JT, Tao SL, editors. Microfluidic Cell Culture Systems. Oxford: William Andrew
Publishing. pp. 279–302.
6. Jang KJ, Mehr AP, Hamilton GA, McPartlin LA, Chung S, et al. (2013) Human kidney proximal tubule-
on-a-chip for drug transport and nephrotoxicity assessment. Integr Biol (Camb).
7. Huang HC, Chang YJ, Chen WC, Harn HI, Tang MJ, et al. (2013) Enhancement of renal epithelial cell
functions through microfluidic-based coculture with adipose-derived stem cells. Tissue Eng Part A 19:
2024–2034. https://doi.org/10.1089/ten.TEA.2012.0605 PMID: 23557379
8. Aydin S, Signorelli S, Lechleitner T, Joannidis M, Pleban C, et al. (2008) Influence of microvascular
endothelial cells on transcriptional regulation of proximal tubular epithelial cells. American Journal of
Physiology-Cell Physiology 294: C543–C554. https://doi.org/10.1152/ajpcell.00307.2007 PMID:
18057119
9. Linas SL, Repine JE (1999) Endothelial cells regulate proximal tubule epithelial cell sodium transport.
Kidney Int 55: 1251–1258. https://doi.org/10.1046/j.1523-1755.1999.00360.x PMID: 10200988
10. Frohlich EM, Alonso JL, Borenstein JT, Zhang X, Arnaout MA, et al. (2013) Topographically-patterned
porous membranes in a microfluidic device as an in vitro model of renal reabsorptive barriers. Lab Chip
13: 2311–2319. https://doi.org/10.1039/c3lc50199j PMID: 23636129
11. Bettinger CJ, Langer R, Borenstein JT (2009) Engineering substrate topography at the micro- and nano-
scale to control cell function. Angew Chem Int Ed Engl 48: 5406–5415. https://doi.org/10.1002/anie.
200805179 PMID: 19492373
12. Charest JL, Bryant LE, Garcia AJ, King WP (2004) Hot embossing for micropatterned cell substrates.
Biomaterials 25: 4767–4775. https://doi.org/10.1016/j.biomaterials.2003.12.011 PMID: 15120523
13. Charest JL, Eliason MT, Garcia AJ, King WP (2006) Combined microscale mechanical topography and
chemical patterns on polymer cell culture substrates. Biomaterials 27: 2487–2494. https://doi.org/10.
1016/j.biomaterials.2005.11.022 PMID: 16325902
14. Charest JL, Eliason MT, Garcia AJ, King WP, Talin AA, et al. (2005) Polymer cell culture substrates with
combined nanotopographical patterns and micropatterned chemical domains. J Vac Sci Tech B 23:
3011–3014.
15. Charest JL, Garcia AJ, King WP (2007) Myoblast alignment and differentiation on cell culture substrates
with microscale topography and model chemistries. Biomaterials 28: 2202–2210. https://doi.org/10.
1016/j.biomaterials.2007.01.020 PMID: 17267031
16. Blattmann A, Denk L, Strehl R, Castrop H, Minuth WW (2008) The formation of pores in the basal lam-
ina of regenerated renal tubules. Biomaterials 29: 2749–2756. https://doi.org/10.1016/j.biomaterials.
2008.03.019 PMID: 18400296
17. Hironaka K, Makino H, Yamasaki Y, Ota Z (1993) Renal basement membranes by ultrahigh resolution
scanning electron microscope. Kidney International 43: 334–345. PMID: 8441229
18. Jang KJ, Suh KY (2010) A multi-layer microfluidic device for efficient culture and analysis of renal tubu-
lar cells. Lab Chip 10: 36–42. https://doi.org/10.1039/b907515a PMID: 20024048
19. Duan Y, Gotoh N, Yan Q, Du Z, Weinstein AM, et al. (2008) Shear-induced reorganization of renal prox-
imal tubule cell actin cytoskeleton and apical junctional complexes. Proc Natl Acad Sci U S A 105:
11418–11423. https://doi.org/10.1073/pnas.0804954105 PMID: 18685100
20. Frohlich EM, Zhang X, Charest JL (2012) The use of controlled surface topography and flow-induced
shear stress to influence renal epithelial cell function. Integr Biol (Camb) 4: 75–83.
21. Maunsbach AB, Christensen EI (2011) Functional Ultrastructure of the Proximal Tubule. Compr Physiol
2011, Supplement 25: Handbook of Physiology, Renal Physiology: 41–107 First published in print 1992
22. Zhang Y, Schedle A, Matejka M, Rausch-Fan X, Andrukhov O (2010) The proliferation and differentia-
tion of osteoblasts in co-culture with human umbilical vein endothelial cells: An improved analysis using
fluorescence-activated cell sorting. Cellular & Molecular Biology Letters 15: 517–529.
A microfluidic proximal tubule
PLOS ONE | https://doi.org/10.1371/journal.pone.0184330 October 11, 2017 13 / 15
23. Yuan Q, Gong P, Li XY, Wei N, Tan Z, et al. (2008) Enhanced proliferation and differentiation of osteo-
blasts induced by co-culturing with Schwann cells. Archives of Medical Science 4: 242–248.
24. Saito K, Yoshikawa M, Ouji Y, Moriya K, Nishiofuku M, et al. (2006) Promoted differentiation of cynomol-
gus monkey ES cells into hepatocyte-like cells by co-culture with mouse fetal liver-derived cells. World
Journal of Gastroenterology 12: 6818–6827. https://doi.org/10.3748/wjg.v12.i42.6818 PMID:
17106931
25. Li XJ, Liao DP, Gong P, Yuan Q, Tan Z (2009) NEURAL DIFFERENTIATION OF ADIPOSE-DERIVED
STEM CELLS BY INDIRECT CO-CULTURE WITH SCHWANN CELLS. Archives of Biological Sci-
ences 61: 703–711.
26. Li Q, Wang ZL (2013) Influence of Mesenchymal Stem Cells with Endothelial Progenitor Cells in Co-cul-
ture on Osteogenesis and Angiogenesis: An In Vitro Study. Archives of Medical Research 44: 504–
513. https://doi.org/10.1016/j.arcmed.2013.09.009 PMID: 24120387
27. Zhang B, Yang SH, Zhang YK, Sun ZB, Xu WH, et al. (2012) Co-culture of mesenchymal stem cells
with umbilical vein endothelial cells under hypoxic condition. Journal of Huazhong University of Science
and Technology-Medical Sciences 32: 173–180.
28. Chen ZJ, Htay A, Dos Santos W, Gillies GT, Fillmore HL, et al. (2009) In vitro angiogenesis by human
umbilical vein endothelial cells (HUVEC) induced by three-dimensional co-culture with glioblastoma
cells. Journal of Neuro-Oncology 92: 121–128. https://doi.org/10.1007/s11060-008-9742-y PMID:
19039523
29. Kim J, Kim HN, Lim KT, Kim Y, Pandey S, et al. (2013) Synergistic effects of nanotopography and co-
culture with endothelial cells on osteogenesis of mesenchymal stem cells. Biomaterials 34: 7257–
7268. https://doi.org/10.1016/j.biomaterials.2013.06.029 PMID: 23834896
30. Zervantonakis IK, Hughes-Alford SK, Charest JL, Condeelis JS, Gertler FB, et al. (2012) Three-dimen-
sional microfluidic model for tumor cell intravasation and endothelial barrier function. Proc Natl Acad Sci
U S A 109: 13515–13520. https://doi.org/10.1073/pnas.1210182109 PMID: 22869695
31. Tufro A, Norwood VF, Carey RM, Gomez RA (1999) Vascular endothelial growth factor induces nephro-
genesis and vasculogenesis. Journal of the American Society of Nephrology 10: 2125–2134. PMID:
10505689
32. Weinberg JM, Molitoris BA (2009) Illuminating mitochondrial function and dysfunction using multiphoton
technology. J Am Soc Nephrol 20: 1164–1166. https://doi.org/10.1681/ASN.2009040419 PMID:
19470668
33. Bruggeman LA, Doan RP, Loftis J, Darr A, Calabro A (2012) A Cell Culture System for the Structure
and Hydrogel Properties of Basement Membranes: Application to Capillary Walls. Cellular and Molecu-
lar Bioengineering 5: 194–204. https://doi.org/10.1007/s12195-012-0221-3 PMID: 23087767
34. Slater SC, Beachley V, Hayes T, Zhang D, Welsh GI, et al. (2011) An in vitro model of the glomerular
capillary wall using electrospun collagen nanofibres in a bioartificial composite basement membrane.
PLoS ONE 6: e20802. https://doi.org/10.1371/journal.pone.0020802 PMID: 21731625
35. Luyts K, Napierska D, Dinsdale D, Klein SG, Serchi T, et al. (2015) A coculture model of the lung—
blood barrier: The role of activated phagocytic cells. Toxicology in Vitro 29: 234–241. https://doi.org/10.
1016/j.tiv.2014.10.024 PMID: 25448809
36. Kumar R, Harris-Hooker S, Sanford G (2011) Co-culture of Retinal and Endothelial Cells Results in the
Modulation of Genes Critical to Retinal Neovascularization. Vasc Cell 3: 27. https://doi.org/10.1186/
2045-824X-3-27 PMID: 22112782
37. Duan Y, Weinstein AM, Weinbaum S, Wang T (2010) Shear stress-induced changes of membrane
transporter localization and expression in mouse proximal tubule cells. Proc Natl Acad Sci U S A 107:
21860–21865. https://doi.org/10.1073/pnas.1015751107 PMID: 21106755
38. Yamada K, Saito M, Matsuoka H, Inagaki N (2007) A real-time method of imaging glucose uptake in sin-
gle, living mammalian cells. Nat Protoc 2: 753–762. https://doi.org/10.1038/nprot.2007.76 PMID:
17406637
39. Humes HD, MacKay SM, Funke AJ, Buffington DA (1999) Tissue engineering of a bioartificial renal
tubule assist device: in vitro transport and metabolic characteristics. Kidney Int 55: 2502–2514. https://
doi.org/10.1046/j.1523-1755.1999.00486.x PMID: 10354300
40. Nguyen AN, Wallace DP, Blanco G (2007) Ouabain binds with high affinity to the Na,K-ATPase in
human polycystic kidney cells and induces extracellular signal-regulated kinase activation and cell pro-
liferation. J Am Soc Nephrol 18: 46–57. https://doi.org/10.1681/ASN.2006010086 PMID: 17151336
41. Yan Y, Haller S, Shapiro A, Malhotra N, Tian J, et al. (2012) Ouabain-stimulated trafficking regulation of
the Na/K-ATPase and NHE3 in renal proximal tubule cells. Mol Cell Biochem 367: 175–183. https://doi.
org/10.1007/s11010-012-1331-x PMID: 22618525
A microfluidic proximal tubule
PLOS ONE | https://doi.org/10.1371/journal.pone.0184330 October 11, 2017 14 / 15
42. Blodgett AB, Kothinti RK, Kamyshko I, Petering DH, Kumar S, et al. (2011) A fluorescence method for
measurement of glucose transport in kidney cells. Diabetes Technol Ther 13: 743–751. https://doi.org/
10.1089/dia.2011.0041 PMID: 21510766
43. Chang HC, Yang SF, Huang CC, Lin TS, Liang PH, et al. (2013) Development of a novel non-radioac-
tive cell-based method for the screening of SGLT1 and SGLT2 inhibitors using 1-NBDG. Mol Biosyst 9:
2010–2020. https://doi.org/10.1039/c3mb70060g PMID: 23657801
44. Kanwal A, Singh SP, Grover P, Banerjee SK (2012) Development of a cell-based nonradioactive glu-
cose uptake assay system for SGLT1 and SGLT2. Anal Biochem 429: 70–75. https://doi.org/10.1016/j.
ab.2012.07.003 PMID: 22796500
45. Weber EJ, Chapron A, Chapron BD, Voellinger JL, Lidberg KA, et al. (2016) Development of a micro-
physiological model of human kidney proximal tubule function. Kidney Int 90: 627–637. https://doi.org/
10.1016/j.kint.2016.06.011 PMID: 27521113
46. Jang KJ, Cho HS, Kang do H, Bae WG, Kwon TH, et al. (2011) Fluid-shear-stress-induced translocation
of aquaporin-2 and reorganization of actin cytoskeleton in renal tubular epithelial cells. Integr Biol
(Camb) 3: 134–141.
47. Kelly EJ, Wang Z, Voellinger JL, Yeung CK, Shen DD, et al. (2013) Innovations in preclinical biology: ex
vivo engineering of a human kidney tissue microperfusion system. Stem Cell Res Ther 4 Suppl 1: S17.
48. Prozialeck WC, Edwards JR, Lamar PC, Smith CS (2006) Epithelial barrier characteristics and expres-
sion of cell adhesion molecules in proximal tubule-derived cell lines commonly used for in vitro toxicity
studies. Toxicol In Vitro 20: 942–953. https://doi.org/10.1016/j.tiv.2005.11.006 PMID: 16387471
49. Jang KJ, Mehr AP, Hamilton GA, McPartlin LA, Chung S, et al. (2013) Human kidney proximal tubule-
on-a-chip for drug transport and nephrotoxicity assessment. Integr Biol (Camb) 5: 1119–1129.
50. Panchapakesan U, Pegg K, Gross S, Komala MG, Mudaliar H, et al. (2013) Effects of SGLT2 inhibition
in human kidney proximal tubular cells—renoprotection in diabetic nephropathy? PLoS ONE 8:
e54442. https://doi.org/10.1371/journal.pone.0054442 PMID: 23390498
A microfluidic proximal tubule
PLOS ONE | https://doi.org/10.1371/journal.pone.0184330 October 11, 2017 15 / 15
